Probiotics are the newest buzzword in the human dietary portfolio, and they are currently attracting a lot of attention throughout the world, particularly in India and other developing countries, thanks to their significant health benefits. Our growing knowledge of the role of the human gut microbiota, as well as the rising usage of probiotic organisms such as lactobacilli and bifidobacteria as functional microbial dietary elements for human health promotion, has had a significant impact on consumers. As a result of recent advances in the science of probiotics in terms of efficacy, mode of action, and probiotic-gut microbiota-host interactions at the molecular level with the aid of high throughput sequencing techniques and nutrigenomics, the application of probiotics offers an innovative approach for the development of novel probiotic formulations under the category of functional foods for the management of specific diseases, particularly chronic inflammatory gastrointestinal diseases.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India